Company: CMND
Filing Date: 2025-06-12
Form Type: POS AM
Source: 0001213900-25-053898
Chunk: 22

Company: Clearmind Medicine Inc.
Filing Date: 2025-06-12
Form: POS AM
Chunk 22
---
 of common shares
issued to the selling shareholders in the “Prospectus Summary – January 2024 Offering” described above and (ii) the
maximum number of common shares issuable upon exercise of the January 2024 PIPE Warrants, determined as if the outstanding January 2024
PIPE Warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed
with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as
provided in the registration rights agreement, without regard to any limitations on the exercise of the January 2024 PIPE Warrants. The
fourth column assumes the sale of all of the common shares offered by the selling shareholders pursuant to this prospectus.

Under the terms of the January 2024 PIPE Warrants,
a selling shareholder may not exercise the January 2024 PIPE Warrants to the extent such exercise would cause such selling shareholder,
together with its affiliates and attribution parties, to beneficially own a number of common shares which would exceed 4.99% or 9.99%,
as applicable, of our then outstanding common shares following such exercise, excluding for purposes of such determination common shares
issuable upon exercise of the January 2024 PIPE Warrants that have not been exercised. The number of common shares in the second column
does not reflect this limitation. The selling shareholders may sell all, some or none of their common shares in this offering. See “Plan
of Distribution.”

| Name                                             
 of Selling Shareholder                           |     | Number         
 of             
 Common Shares  
 Owned Prior to 
 Offering       |         |     |     | Maximum                           
 Number of                         
 Common Shares to be Sold Pursuant 
 to this                           
 Prospectus                        |         |     |     | Number        
 of            
 Common Shares 
 Owned After   
 Offering      |         |     |     | Percentage   
 of           
 Ordinary     
 Shares Owned 
 After the    
 Offering     |      |   |
| Lind Global Fund II LP (1)                       |     |                | 187,500 |  -2 |     |                                   | 187,500 |  -2 |     |               |       - |     |     |              |    - | % |
| Iroquois Capital Investment Group LLC (3)        |     |                | 201,419 |  -4 |     |                                   | 187,500 |  -5 |     |               |  13,919 |